Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions

Journal of Clinical Epidemiology

Volumn 60, Issue 7, 2007, Pages 720-726

  Lubsen, Jacobus ^a,b   Vokó, Zoltán ^c   Poole Wilson, Philip A ^d   Kirwan, Bridget Anne ^a   de Brouwer, Sophie ^a  

^a SOCAR RESEARCH SA   (Switzerland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Medical and Health Sciences Centre   (Hungary)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Angina pectoris; Blood pressure change; Coronary artery disease; Covariance analysis; Nifedipine; Regression to the mean

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NIFEDIPINE; ORGANIC NITRATE; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE REGULATION; BYPASS SURGERY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK REDUCTION; STABLE ANGINA PECTORIS; STROKE;

ANGINA PECTORIS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIAC OUTPUT, LOW; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NIFEDIPINE; TREATMENT OUTCOME;

EID: 34250022182     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2006.10.015     Document Type: Article

References (14)

1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
2. Poole-Wilson P.A., Lubsen J., Kirwan B.A., van Dalen F.J., Wagener G., Danchin N., et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 364 (2004) 849-857
3. Lubsen J., Wagener G., Kirwan B.A., de Brouwer S., and Poole-Wilson P.A. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial. J Hypertens 23 (2005) 641-648
4. Vickers A.J., and Altman D.G. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 323 (2001) 1123-1124
5. Lubsen J., Poole-Wilson P.A., Pocock S.J., van Dalen F.J., Baumann J., Kirwan B.A., et al. Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System. Eur Heart J 19 Suppl 1 (1998) I20-I32
6. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321 (1989) 406-412
7. Bland J.M., and Altman D.G. Some examples of regression towards the mean. BMJ 309 (1994) 780
8. Bland J.M., and Altman D.G. Regression towards the mean. BMJ 308 (1994) 1499
9. Staessen J.A., Li Y., Thijs L., and Wang J.G. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res 28 (2005) 385-407
10. Hansson L., Zanchetti A., Carruthers S.G., Dahlof B., Elmfeldt D., Julius S., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT study group. Lancet 351 (1998) 1755-1762
11. Black H.R. The burden of cardiovascular disease: following the link from hypertension to myocardial infarction and heart failure. Am J Hypertens 16 (2003) 4S-6S
12. Lawes C.M., Bennett D.A., Feigin V.L., and Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 35 (2004) 1024-1033
13. Beevers D.G. Epidemiological, pathophysiological and clinical significance of systolic, diastolic and pulse pressure. J Hum Hypertens 18 (2004) 531-533
14. Hoes A.W., Grobbee D.E., and Lubsen J. Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertens 13 (1995) 805-811